Boekhorst Paul Francis Olivier Te serves as Executive at IMMUCELL CORP /DE/, where they oversee executive responsibilities. Since joining the company, Boekhorst Paul Francis Olivier Te has executed 6 insider transactions totaling $80.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 27, 2026 involved receiving (via award) 110,000 shares valued at $0.
Boekhorst Paul Francis Olivier Te currently holds 110,000 shares of IMMUCELL CORP /DE/ (ICCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Boekhorst Paul Francis Olivier Te has been a net buyer of ICCC stock. They have purchased $80.1K and sold $0 worth of shares.
Boekhorst Paul Francis Olivier Te's most recent insider trade was on Jan 27, 2026, when they sold 110,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $5.50 |
| Discretionary |
| Dec 3, 2025 | ICCC | $17.7K | Purchase | 3,521 | $5.04 | Discretionary |
| Dec 3, 2025 | ICCC | $12.8K | Purchase | 2,556 | $5.00 | Discretionary |
| Dec 3, 2025 | ICCC | $18.2K | Purchase | 3,598 | $5.05 | Discretionary |
| Dec 2, 2025 | ICCC | $18.1K | Purchase | 3,708 | $4.87 | Discretionary |